Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Major Japanese Photo Firm Plans Toyama Buy To Enter Drug Market

This article was originally published in PharmAsia News

Executive Summary

Fujifilm Holdings plans to acquire Toyama Chemical to make the Japanese pharmaceutical company its first major venture into the drug industry. Fujifilm sees the acquisition worth $9.2 billion in annual sales in 10 years, triple current Fujifilm sales. Fujifilm's president said his company plans other mergers and acquisitions in the medical business to replace the photography business, which has been changed by digital cameras. The Toyama takeover is the latest of a string of 20 takeovers under company president Shigetaka Komori. (Click here for more - a subscription may be required
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC067654

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel